↓ Skip to main content

Low-dose endotoxin inhalation in healthy volunteers - a challenge model for early clinical drug development

Overview of attention for article published in BMC Pulmonary Medicine, March 2013
Altmetric Badge

Mentioned by

twitter
4 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Low-dose endotoxin inhalation in healthy volunteers - a challenge model for early clinical drug development
Published in
BMC Pulmonary Medicine, March 2013
DOI 10.1186/1471-2466-13-19
Pubmed ID
Authors

Ole Janssen, Frank Schaumann, Olaf Holz, Bianca Lavae-Mokhtari, Lutz Welker, Carla Winkler, Heike Biller, Norbert Krug, Jens M Hohlfeld

Abstract

Inhalation of endotoxin (LPS) induces a predominantly neutrophilic airway inflammation and has been used as model to test the anti-inflammatory activity of novel drugs. In the past, a dose exceeding 15-50 μg was generally needed to induce a sufficient inflammatory response. For human studies, regulatory authorities in some countries now request the use of GMP-grade LPS, which is of limited availability. It was therefore the aim of this study to test the effect and reproducibility of a low-dose LPS challenge (20,000 E.U.; 2 μg) using a flow- and volume-controlled inhalation technique to increase LPS deposition.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 2%
Unknown 43 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 11 25%
Researcher 10 23%
Student > Bachelor 4 9%
Professor 3 7%
Student > Postgraduate 2 5%
Other 6 14%
Unknown 8 18%
Readers by discipline Count As %
Medicine and Dentistry 12 27%
Agricultural and Biological Sciences 10 23%
Pharmacology, Toxicology and Pharmaceutical Science 4 9%
Biochemistry, Genetics and Molecular Biology 2 5%
Environmental Science 1 2%
Other 4 9%
Unknown 11 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 March 2013.
All research outputs
#15,267,294
of 22,703,044 outputs
Outputs from BMC Pulmonary Medicine
#1,072
of 1,895 outputs
Outputs of similar age
#123,827
of 197,824 outputs
Outputs of similar age from BMC Pulmonary Medicine
#14
of 19 outputs
Altmetric has tracked 22,703,044 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,895 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 34th percentile – i.e., 34% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 197,824 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.